Tumoral and angiogenesis factors in hepatocellular carcinoma after locoregional therapy
Authors:
- Alton B. FarrisAFAlton B. Farris
- Nevra DursunNDNevra Dursun
- Renumathy DhanasekaranRDRenumathy Dhanasekaran
- Ipek CobanICIpek Coban
- Emily B. McIntoshEMEmily B. McIntosh
- N. Volkan AdsayNAN. Volkan Adsay
- Hyun S. KimHKHyun S. Kim
- 1 January 2012
- journal article
- Published by Elsevier in Pathology - Research and Practice
- Vol. 208 (1) , 15-21
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Increased vascular endothelial growth factor transcription in residual hepatocellular carcinoma after open versus laparoscopic hepatectomy in a small animal modelSurgical Endoscopy, 2009
- Liver transplantation after radioembolization in a patient with unresectable HCCNature Reviews Gastroenterology & Hepatology, 2009
- Multistep human hepatocarcinogenesis: correlation of imaging with pathologyJournal of Gastroenterology, 2009
- Liver transplantation for hepatocellular carcinomaWorld Journal of Gastroenterology, 2009
- FLT1 and its ligands VEGFB and PlGF: drug targets for anti-angiogenic therapy?Nature Reviews Cancer, 2008
- Molecular targeted therapies in hepatocellular carcinoma†Hepatology, 2008
- Sorafenib in Advanced Hepatocellular CarcinomaNew England Journal of Medicine, 2008
- Hepatocellular carcinoma pathogenesis: from genes to environmentNature Reviews Cancer, 2006
- Prognostic Histologic Indicators of Curatively Resected Hepatocellular CarcinomasAmerican Journal of Surgical Pathology, 2002
- A Model to Predict Survival in Patients With End–Stage Liver DiseaseHepatology, 2001